# Remdesivir Efficacy In Management Of COVID-19 Patients

> **NCT04853901** · PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 77 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Remdesivir
- **DRUG:** Standard of care_1
- **DRUG:** Standard of care_2

## Key facts

- **NCT ID:** NCT04853901
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-27
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-03-01
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2021-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04853901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04853901, "Remdesivir Efficacy In Management Of COVID-19 Patients". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT04853901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*